In this study, the phenotype of AMs in HIV patients with COPD was characterized into four subgroups classified as M1 (CD40+CD163−), M2 (CD40−CD163+), double positives (CD40+CD163+), and double negatives (CD40−CD163−) [138]. Here, CD163 is linked to chronic obstructive pulmonary disease.